CAS: 10441-27-7; 3-Acetyl-7-Hydroxy-2H-Chromen-2-One

该化合物是丙氨酸衍生物,其特征是3位置有乙酰集团存在,7位置有氢氧基组,该化合物具有显著的光物理特性,因为它具有共聚的铬-2-1-1核心,在基于荧光的用途中有用;氢氧基组增强了极溶剂中的溶解性,并为进一步发挥作用提供了一个反应场所;其结构特征有助于潜在的生物活动,包括抗氧化剂和抗炎效应,这在药用化学研究中很有意义;乙酰胺运动提供了更多的稳定性和影响其电子特性,使它成为合成更复杂的基于孔素的化合物的多功能中间体;其明确界定的结构有助于对药物发现和物质科学应用进行精确的修改.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

ethyl acetoacetate 2,4-Dihydroxybenzaldehyde 2-ethoxymethylene-3-oxobutanoic acid ethyl ester recorcinol bis[2,4-dihydroxybenzaldehyde]hydrazone 3-acetyl-7-phenyl-2H-chromen-2-one 3-acetyl-7-p-tolyl-2H-chromen-2-one

合成工艺路线路线简述

    📜3-乙酰基-7-甲氧基香豆素置于aluminum (III) Chloride体系中,用 甲苯 用作溶剂,化学反应 3.0H,以68%的收率获得3-乙酰基-7-羟基-苯并吡喃-2-酮
    参考文献:(6-和7-苯基)香豆素衍生物的合成及生物评价作为17β-羟基甾体脱氢酶1型的选择性非甾体抑制剂
    标题:(6-和7-苯基)香豆素衍生物的合成及生物评价作为17β-羟基甾体脱氢酶1型的选择性非甾体抑制剂
    摘要:17β-羟基类固醇脱氢酶1(17β-Hsd1)是一种酶,可催化nadph依赖性的弱雌激素雌酮还原为最有效的雌激素雌二醇,后者通过雌激素受体发挥增殖作用.17β-Hsd1在雌激素反应性组织中的过表达与激素依赖性疾病的发展有关,例如乳腺癌和子宫内膜异位症.因此,17β-Hsd1代表了开发新疗法的诱人靶标.我们发现,在重组酶分析中,简单的香豆素1和2可以显着抑制17β-Hsd1,对17β-Hsd2具有高选择性.我们假设引入了各种p-使用suzuki-Miyaura交叉偶联反应将香豆素核心的6或7位取代的苯基部分提供类固醇结构的模拟物,对17β-Hsd1的抑制作用得到改善.该系列中最好的抑制剂被证明是6A,Ic 50为270 Nm,对17β-Hsd1的选择性比对17β-Hsd2的要好,并且对α和β雌激素受体的选择性也很高.
    Doi:10.1021/jm101104Z

    海关参考信息

    专利信息


    专利号:US-2023037284-A9
    优先权日:2018-11-30
    标题:Combination therapy of peptidomimetic macrocycles
    发明人:GUERLAVAIS VINCENT; ANNIS DAVID ALLEN
    权利人:AILERON THERAPEUTICS INC
    摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.

    专利号:US-2018371021-A1
    优先权日:2017-05-11
    标 题 :Peptidomimetic macrocycles and uses thereof
    发明人:AIVADO MANUEL; GUERLAVAIS VINCENT; OLSON KAREN
    权利人:AILERON THERAPEUTICS INC
    摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.

    专利号:US-11091522-B2
    优先权日:2018-07-23
    标题 :Peptidomimetic macrocycles and uses thereof
    发明人:AIVADO MANUEL; GUERLAVAIS VINCENT; OLSON KAREN; ANNIS DAVID ALLEN
    权利人:AILERON THERAPEUTICS INC
    摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.

    专利号:US-7041812-B2
    优先权日:2001-08-29
    标题 :Labeled nucleoside polyphosphates
    发明人:KUMAR SHIV; SOOD ANUP
    权利人:AMERSHAM BIOSCIENCES CORP
    摘要:The present invention describes new compositions of matter in the form of labeled nucleoside polyphosphates with four or more phosphates. In addition compositions of nucleoside polyphosphates with four or more phosphates that are substrates for nucleic acid polymerases with enhanced substrate properties and methods of using these nucleoside polyphosphates for nucleic acid detection, characterization and quantification are described. The compositions provided by this invention include nucleoside polyphosphate, dideoxynucleoside polyphosphate, or deoxynucleoside polyphosphate analogues which have colorimetric, chemiluminescent, or fluorescent moieties, mass tags or an electrochemical tags attached to the terminal-phosphate. When a nucleic acid polymerase uses this analogue as a substrate, an enzyme-activatable label would be present on the inorganic polyphosphate by-product of phosphoryl transfer. Removal of the polyphosphate product of phosphoryl transfer via phosphate or polyphosphate transferring enzyme leads to a detectable change in the label attached thereon. When the polymerase assay is performed in the presence of a phosphatase, there is provided a convenient method for real-time monitoring of DNA or RNA synthesis and detection of a target nucleic acid.

    专利号:US-7563574-B2
    优先权日:2006-03-31
    标题:Methods, systems and compositions for monitoring enzyme activity and applications thereof
    发明人:KORLACH JONAS; TURNER STEPHEN
    权利人:PACIFIC BIOSCIENCES CALIFORNIA
    摘要:Methods of monitoring enzyme mediated reactions, and particularly nucleic acid synthesis reactions such as pyrosequencing methods that employ enzymatic reporter systems. The methods and systems provide elevated signal levels as compared to conventional pyrosequencing processes, and/or mediate de-phasing of sequencing analyses employing pyrosequencing or other “sequencing by synthesisâ€? methods.

    专利号:CN-116444472-A
    优先权日:2022-11-11
    标 题 :Effective synthesis method of 7-hydroxy 3-methyl ketocoumarin

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s00604-019-3590-7
    摘要:Fu L, Du Y, Zhang Z, Sun H, Zheng A, Liu X. Dual sensing of glutathione and acidic pH values by using MnO2 nanosheets and 3-acetyl-7-hydroxy-2H-chromen-2-one as a fluorescent pH probe. Mikrochim Acta. 2019 Jul 02;186(8):491. doi: 10.1007/s00604-019-3590-7.
    参考文献:10.1078/0944-7113-00036
    摘要:Cottiglia F, Loy G, Garau D, Floris C, Casu M, Pompei R, Bonsignore L. Antimicrobial evaluation of coumarins and flavonoids from the stems of Daphne gnidium L. Phytomedicine. 2001 Jul;8(4):302–5. doi: 10.1078/0944-7113-00036.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知